Loading...
After undergoing orchiectomy, men with stage I nonseminoma germ cell tumors (NSGCT) can be managed with retroperitoneal lymph node dissection (RPLND), adjuvant chemotherapy (cisplatin, etoposide, and bleomycin), or surveillance. Regardless of how patients are managed, the cure rates of these patients are in the range of 98% to 99%.
To examine outcomes associated with surveillance, investigators reviewed the records of 1226 men in the Danish National Patient Register who were observed after orchiectomy for stage I NSGCT between 1984 and 2007. Most patients had tumor markers drawn monthly during year 1, every 3 months during year 2, and every 6 months during years 3 to 5. Computed tomography (CT) imaging was performed at 4, 8, 12, 36, and 60 m…